Regenerative endodontic procedure using Emdogain: a case series.

IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL
Karime Tavares Lima da Silva, Meire Coelho Ferreira, Renata Grazziotin-Soares, Letícia Gomes Dourado, Claudia de Castro Rizzi Maia, Gisele Rodrigues da Silva, Ceci Nunes Carvalho
{"title":"Regenerative endodontic procedure using Emdogain: a case series.","authors":"Karime Tavares Lima da Silva, Meire Coelho Ferreira, Renata Grazziotin-Soares, Letícia Gomes Dourado, Claudia de Castro Rizzi Maia, Gisele Rodrigues da Silva, Ceci Nunes Carvalho","doi":"10.1186/s13256-025-05199-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Emdogain (Straumann<sup>®</sup> Emdogain<sup>®</sup>, Basel, Switzerland) is an enamel matrix derivative and has an important role in odontogenesis, by potentializing pulp tissue repair and regeneration, as showed in biological studies. Nevertheless, the benefits of using Emdogain as a scaffold in clinical regenerative endodontic procedures has not been demonstrated and is not yet fully understood. The aim of this report was to show three clinical cases that had different preoperative conditions and underwent pulp regenerative procedures under an identical clinical protocol. This report also aimed to show the value of using Emdogain to guide angiogenesis and the healing process by reporting clinical and radiographical results. This is a pioneering study on the use of Emdogain in regenerative endodontic procedures in humans.</p><p><strong>Cases presentation: </strong>This report is a retrospective description of clinical findings from three regenerative treatments conducted under an identical protocol in two appointments using Emdogain as a scaffold. The three young Brazilian patients, aged 8, 8, and 12 years old (one female and two male), are from São Luís city, state of Maranhão. All three patients identify as Pardo ethnicity with brown skin color, come from low-income backgrounds, and had necrotic immature permanent teeth. Quantitative assessments of crown shades of treated teeth were determined with VITA Easyshade® Advance 4.0 spectrophotometer (VITA Zahnfabrik, Bad Sackingen, Germany) at baseline to 24-month follow-up. Self-reported pain was measured using the visual analogue scale (VAS) at the time of treatment (shortly after induction of bleeding into the canal) and at 7 day following the procedure. At 12 months, radiographic lesions were resolved. At 24 months there were apical closures, and the three teeth remained in function without symptomatology or signs of failure. All cases had the root length increased and the dentin wall thickened. One case presented radiographic images suggestive of scattered calcified zones in the root canal lumen.</p><p><strong>Conclusion: </strong>Emdogain may be beneficial as a scaffold in regenerative endodontic procedures. The following outcomes were noted at 24-month follow-up: continuity of root formation, thickening of the root dentin walls, and closure of the root apex.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"19 1","pages":"205"},"PeriodicalIF":0.9000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046937/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13256-025-05199-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Emdogain (Straumann® Emdogain®, Basel, Switzerland) is an enamel matrix derivative and has an important role in odontogenesis, by potentializing pulp tissue repair and regeneration, as showed in biological studies. Nevertheless, the benefits of using Emdogain as a scaffold in clinical regenerative endodontic procedures has not been demonstrated and is not yet fully understood. The aim of this report was to show three clinical cases that had different preoperative conditions and underwent pulp regenerative procedures under an identical clinical protocol. This report also aimed to show the value of using Emdogain to guide angiogenesis and the healing process by reporting clinical and radiographical results. This is a pioneering study on the use of Emdogain in regenerative endodontic procedures in humans.

Cases presentation: This report is a retrospective description of clinical findings from three regenerative treatments conducted under an identical protocol in two appointments using Emdogain as a scaffold. The three young Brazilian patients, aged 8, 8, and 12 years old (one female and two male), are from São Luís city, state of Maranhão. All three patients identify as Pardo ethnicity with brown skin color, come from low-income backgrounds, and had necrotic immature permanent teeth. Quantitative assessments of crown shades of treated teeth were determined with VITA Easyshade® Advance 4.0 spectrophotometer (VITA Zahnfabrik, Bad Sackingen, Germany) at baseline to 24-month follow-up. Self-reported pain was measured using the visual analogue scale (VAS) at the time of treatment (shortly after induction of bleeding into the canal) and at 7 day following the procedure. At 12 months, radiographic lesions were resolved. At 24 months there were apical closures, and the three teeth remained in function without symptomatology or signs of failure. All cases had the root length increased and the dentin wall thickened. One case presented radiographic images suggestive of scattered calcified zones in the root canal lumen.

Conclusion: Emdogain may be beneficial as a scaffold in regenerative endodontic procedures. The following outcomes were noted at 24-month follow-up: continuity of root formation, thickening of the root dentin walls, and closure of the root apex.

使用Emdogain的再生牙髓治疗:一个病例系列。
背景:Emdogain (Straumann®Emdogain®,Basel, Switzerland)是一种牙釉质基质衍生物,生物学研究表明,Emdogain通过潜在的牙髓组织修复和再生,在牙髓形成中发挥重要作用。然而,在临床再生牙髓治疗中使用Emdogain作为支架的益处尚未得到证实,也尚未完全了解。本报告的目的是显示三个临床病例有不同的术前条件,并在相同的临床方案下进行牙髓再生手术。本报告还旨在通过报告临床和影像学结果来显示使用Emdogain指导血管生成和愈合过程的价值。这是一项关于Emdogain在人类再生牙髓治疗中的应用的开创性研究。病例介绍:本报告回顾性描述了两次使用Emdogain作为支架,在相同方案下进行的三次再生治疗的临床结果。3名年龄分别为8岁、8岁和12岁的巴西年轻患者(1名女性和2名男性)来自maranh州s o Luís市。三名患者均为Pardo族,棕色皮肤,来自低收入家庭,有坏死的未成熟恒牙。在基线至24个月的随访期间,使用VITA Easyshade®Advance 4.0分光光度计(VITA Zahnfabrik, Bad Sackingen, Germany)对治疗后牙齿的冠色度进行定量评估。在治疗时(诱导管内出血后不久)和手术后7天,使用视觉模拟量表(VAS)测量自我报告的疼痛。12个月时,影像学病变消退。在24个月时,有根尖闭合,三颗牙齿保持功能,没有症状或失败的迹象。所有病例根长增加,牙本质壁增厚。1例影像学表现为根管腔内散在钙化区。结论:Emdogain可作为再生牙髓治疗的支架。在24个月的随访中观察到以下结果:根形成的连续性,根牙本质壁增厚,根尖闭合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medical Case Reports
Journal of Medical Case Reports Medicine-Medicine (all)
CiteScore
1.50
自引率
0.00%
发文量
436
期刊介绍: JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信